Agili-C

País: Israel

Língua: hebraico

Origem: Ministry of Health

Disponível em:

Cartiheal (2009) Ltd.

Classe:

בית חולים

Fabricado por:

Cartiheal (2009) Ltd.

Grupo terapêutico:

רופא

Indicações terapêuticas:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.

Resumo do produto:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.